Search
Menu
CASTECH INC - New Building the Bridge of Light

Affymetrix Inc.

Facebook X LinkedIn Email
Affymetrix Inc. of Santa Clara, Calif., has given nonexclusive access to Epigenomics AG of Berlin for its microarray technology. With this agreement, the German company will be able to develop and market microarray-based in vitro diagnostic tests for cancer and other diseases using Affymetrix’s DNA methylation methods.Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: September 2006
    BiophotonicsBusinessRapidScan

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.